Psychosomatic Medicine Faster Service from Outside North America
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published online before print November 8, 2007, 10.1097/PSY.0b013e3181572799
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shaw, R. J.
Right arrow Articles by Joshi, S. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shaw, R. J.
Right arrow Articles by Joshi, S. V.
Related Collections
Right arrow Dermatology
Right arrow Reviews
Psychosomatic Medicine 69:970-978 (2007)
© 2007 American Psychosomatic Society


ORIGINAL ARTICLES

Psychiatric Medications for the Treatment of Pruritus

Richard J. Shaw, MB, BS, Shaili Dayal, MB, BS, Julie Good, MD, Anna L. Bruckner, MD and Shashank V. Joshi, MD

From the Department of Psychiatry and Behavioral Sciences (R.J.S., S.D., S.V.J.) and Department of Pediatrics (J.G., A.L.B.), Stanford University School of Medicine, and Lucile Packard Children's Hospital, Palo Alto, California.

Address correspondence and reprint requests to Richard Shaw, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Road, Palo Alto, CA 94305-5719.

Objectives: To review the use of psychiatric medications in the treatment of pruritus.

Methods: A literature review was conducted using the key words pruritus, psychiatric, and treatment.

Results: Three categories of pruritus are described: dermatologic, systemic, and psychogenic. Peripheral and central nervous system mechanisms of pruritus are reviewed. Conventional dermatologic treatments for pruritus are contrasted with some of the common psychopharmacologic treatment modalities that include anxiolytic, antidepressant, and antipsychotic agents. A treatment algorithm is offered to help guide the treatment of patients with pruritus.

Conclusions: Psychiatric medications have been used successfully in the treatment of pruritus that is associated with both psychocutaneous and systemic disorders, which are resistant to conventional treatment.

Key Words: pruritus • psychopharmacology • treatment • psychocutaneous

Abbreviations: 5HT = hydroxytryptamine; PGE2 = prostaglandin E2; SSRI = selective serotonin reuptake inhibitor; TCA = tricyclic antidepressant.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Psychosomatic Society